Antiviral compounds
US6852731B2 · kind B2 · utility
13Cited by
12References
64Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 14, 2003 |
| Grant date | Feb 8, 2005 |
| Priority date | — |
| Expiry date | Jan 14, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a compound of formula I: wherein G, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.